KdT Ventures
Venture capitalAustin · Pre-Seed–Series A · 11 people tracked
Also known as KDT VENTURES LLC
Investment thesis
KdT invests at the earliest stages in frontier science, viewing science as the underlying 'source code' of reality. The firm backs founders who commercialize breakthroughs across biology, chemistry, physics, and computation, enabled by modern instrumentation, simulation, and AI that allow reading, interpreting, and redesigning the deepest layers of the physical world. It focuses on platform companies capable of engineering matter, energy, and information in new ways, spanning from atoms to bits. KdT also emphasizes long-term, deep relationships with portfolio companies and partners under its 'Venture for Science' approach.
Source: firm website, verified Aug 3, 2026.
Team · 11 people
from the firm's website & public directories
What they invest in
from 34 of 52 portfolio companiesBiotech ×23AI & Machine Learning ×13Healthtech ×11Deep Tech ×7Digital Health ×6Medical Devices ×5Cleantech ×4Climate Tech ×3
HQs:United States×21
Investments · 52 tracked
founders shown can be your intro pathBiotechFarmington, US
Azim Munivar(Executive Officer, Director, Promoter)Stella Robertson(Director)Travis Whitfill(Executive Officer, Director, Promoter)
Board seatCain McClary· per SEC Form D
Faeth Therapeutics develops PIKTOR, an oral multi-node inhibitor targeting the PI3K/AKT/mTOR pathway for cancer treatment, currently in clinical trials for endometrial and breast cancer.
BiotechDigital HealthMedical DevicesAustin, US
Anand Parikh(Executive Officer, Director, Promoter)Oliver Maddocks(Executive Officer, Director)
BoardAlex Morgan(Director)Jayson Dallas(Director)Robert Gould(Director)Stephen Hahn(Director)
Solugen develops a biomanufacturing platform using fermentation and bioprocessing technology to produce specialty chemicals at scale.
Advanced ManufacturingBiotechCleantechClimate TechHealthtechHouston, US
Sean Hunt(Founder/CTO)inGaurab Chakrabarti(Founder)in
BoardSeth Bannon(Director)
Emeryville, US
Board seatPhil Grayeski· per SEC Form D · $16.3M raise · filed Aug 2021
Checkerspot develops high-performance fats and oils using precision fermentation technology, targeting food, nutrition, and other industrial applications.
BiotechClimate TechFoodTechAlameda, US
James Kim(Director)John Krzywicki(CEO)Eric Hartz(Director)Layla Ward(CFO)Scott Franklin(Executive Officer, Director)Cain McClary(Director)
Board seatAndrew Cain McClaryCain McClary· per SEC Form D
Specialty enzyme solutions combined with continuous manufacturing.
Advanced ManufacturingCarlsbad, US
Cain A. McClary(Director)Joshua Britton(Executive Officer, Director)
Board seatCain McClary· per SEC Form D · $2.6M raise · filed Jan 2020
BiotechSan Francisco, US
Mubhij Ahmad(Executive Officer, Director)David Rabuka(Director)Timothy Paul Day(Director)Andrew Cain McClary(Director)Drew Lanza(Director)
Board seatAndrew Cain McClary· per SEC Form D · $8.9M raise · filed Apr 2022
San Carlos, US
Board seatCain McClary· per SEC Form D · $36M raise · filed May 2024
Jamaica Plain, US
Board seatPhil Grayeski· per SEC Form D · $1M raise · filed Jul 2021
Abridge builds AI software that converts clinical conversations into structured insights for healthcare providers.
AI & Machine LearningDigital HealthHealthtech
Shiv Rao(Founder & CEO)Julia Chapin(Executive Officer)Sagar Sanghvi(Executive Officer)Andy Weissman(Director)Sebastian Duesterhoeft(Director)Will Reed(Director)
Andes adds beneficial soil microorganisms alongside agricultural seeds such as corn, soybean, canola, and wheat to accelerate the conversion of atmospheric CO₂ into soil inorganic carbon for durable carbon removal.
AgTechCleantechClimate Tech
Aperiam Bio uses computational methods to identify stabilizing mutations in proteins, producing variants with improved expression, solubility, and activity for applications in technical reagents, cosmetics, and pulmonary therapeutics.
AI & Machine LearningBiotechDeep TechAustin, US
Austin Cole(Executive Officer, Director)
Braid Health combines AI imaging copilots with board-certified radiologists to provide second opinions on MRI, CT, and ultrasound scans, along with AI-generated explanations and workflow tools.
AI & Machine LearningDigital HealthHealthtech
Creasallis develops CreaTap, a patented "plug-and-play" antibody modification technology that improves the penetration of antibody-based drugs into solid tumours, applicable to monoclonal, bispecific, and antibody-drug conjugates.
Biotech
Zahra Jawad(Founder)
Dimension Bio is a biotechnology company that designs and manufactures regenerative therapeutics using its BioNidum™ platform to restore tissue function lost to disease, trauma, or aging.
BiotechHealthtechNew MaterialsChicago, US
Caralynn Nowinski Collens, M.D.(Co-founder & CEO)Ramille Shah, Ph.D.(Co-founder & CSO)Rima Chakrabarti(Director)Ramille Shah(Director)Caralynn Collens(Executive Officer, Director)
Dyno Therapeutics develops artificial intelligence-powered genetic technologies for gene therapy, specifically engineering adeno-associated virus (AAV) capsids to improve gene delivery for treating genetic diseases.
AI & Machine LearningBiotechWatertown, US
Eric Kelsic(CEO & Cofounder)Sam Sinai(Vice President, Head of ML & Cofounder)Adrian Veres(Chief Scientific Officer & Cofounder)George Church(Scientific Cofounder)Tomas Bjorklund(Scientific Co-founder)Alan Crane(Executive Chairman & Cofounder, Polaris Entrepreneur Partner)
Epana Bio develops therapies for autoimmune diseases by leveraging genomics and AI to identify and target cellular origins of disease, with a focus on precision medicine for patient populations.
AI & Machine LearningBiotechDigital Health
Exthymic is a company working on cell therapy manufacturing, aiming to make cancer cell therapies more accessible to patients who currently cannot obtain them.
BiotechHealthtechSan Diego, US
Rich Stoner(Executive Officer, Director)
Index Bio develops AI agents and DNA-labeled microbial tracers (BioTags) that help food manufacturing and safety teams automate investigations, predict contamination risks, and prepare for audits by turning fragmented operational data into structured molecular evidence.
AI & Machine LearningEnterprise SoftwareFoodTech
MacroCycle uses a proprietary chemical process called SolvoGenesis, based on solvent systems and macrocyclic chemistry, to convert textile waste into pure polyester resin at low cost.
Circular EconomyCleantechNew Materials
March Bioscience is a cell therapy company assembling leading scientists and drug developers to advance cell therapy treatments.
BiotechMedical DevicesHouston, US
Sarah Hein(CEO, Co-Founder)inMaksim Mamonkin(Co-Founder, Chair Scientific Advisory Board)Malcolm Brenner(Co-founder)
BoardThomas Luby(Director)inPeter Olagunju(Director)inJoseph Petrosino(Director)
Marigold is an anonymous community platform for people with mental health or substance use challenges, offering peer support and one-on-one coaching from certified peer recovery coaches trained in recovery support.
HealthtechMental Health
Nosis develops a platform for receptor-targeted delivery of RNA therapeutics to specific cell types, addressing a key bottleneck in RNA drug development.
AI & Machine LearningBiotechDeep TechMedical Devices
Onc.AI develops the Onclara platform, which uses oncology real-world data to build predictive and prognostic AI models for cancer decision-making.
AI & Machine LearningBiotechDigital Health
AI-powered pathology for improved patient outcomes
Boston, US
ANDREW BECK(Executive Officer, Director)ADITYA KHOSLA(Executive Officer, Director)STANLEY LAPIDUS(Director)JEFF LEIDEN(Director)MICHELLE DIPP(Director)
Perceptive applies AI and robotics technology to dental practice, helping dentists increase patient capacity.
AI & Machine LearningHealthtechMedical DevicesRoboticsBoston, US
Chris Ciriello(Founder)inScott Phillips(Founder)inPhil Getto(CTO)Alex Furleigh(Chief of Staff)
PHNX Materials refines industrial waste and byproduct streams into critical metals such as gallium, germanium, and silicon, along with products for the building materials and agriculture industries.
Circular EconomyCleantechNew Materials
Rejuvenate Bio develops gene therapy treatments targeting the root causes of aging to address chronic diseases such as osteoarthritis, heart disease, and cancer in companion animals and humans.
BiotechHealthtechLongevitySan Diego, US
Noah Davidsohn(Executive Officer, Director)David Zhu(Director)Daniel Oliver(Executive Officer, Director)
Tacit develops RNA repair technology called Splicing-Directed Repair, which uses naturally-occurring biological systems to fix genetic mutations as an alternative to conventional gene editing.
BiotechDeep TechHealthtech
Terray Therapeutics develops small molecule drugs using its EMMI platform, which combines proprietary hardware, custom-generated datasets, and AI models for drug discovery.
AI & Machine LearningBiotechDeep Tech
Theator is a surgical intelligence platform that analyzes surgical video and converts it into structured data for surgeons, hospital executives, and revenue cycle teams.
AI & Machine LearningDigital HealthHealthtechPalo Alto, US
Dotan Asslemann(Director)Gigi Levy Weiss(Director)Tamir Wolf(Executive Officer, Director)
Tierra Biosciences develops high-performance protein design technology, serving biotechnology and pharmaceutical industries.
Biotech
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does KdT Ventures invest at?
- KdT Ventures invests at the Pre-Seed, Seed, Series A stages.
- What is KdT Ventures's typical check size?
- KdT Ventures typically writes checks of $500K – $3M.
- What sectors does KdT Ventures focus on?
- KdT Ventures focuses on AI & Machine Learning, Biotech, Climate Tech, Deep Tech, New Materials.
- Where is KdT Ventures located?
- KdT Ventures is headquartered in Austin, US.
- Does KdT Ventures lead rounds?
- KdT Ventures typically participates in rounds rather than leading them.
Media · Podcasts & interviews
featuring the teamVentures #3 w/ Phil Grayeski - Partner @ KdT Ventures | BIOS
BIOS · Phil Grayeski
Building Relationships in Pharma 😊 w/ Cain McClary - Founder & Managing Partner @ KdT Ventures
BIOS · Cain McClary
Leaders on a Mission - Cain McClary, Founder& Managing Partner, KdT Ventures, Episode 35
Leaders on a Mission · Cain McClary
Images
Co-investors · 6
Andreessen Horowitz's Strategic Partnerships page describes collaborations that connect its portfolio companies with established institutions to help scale and deploy their technology.
Madrona Venture Group is an early-stage venture capital firm that backs founding teams at seed, early, and acceleration stages, primarily in Seattle, the Bay Area, and beyond.
Lifeforce Capital is a venture firm investing in software companies transforming large healthcare markets.
Mayfield Fund is a venture capital firm publishing perspectives on artificial intelligence, focusing on what it calls the Collaborative Intelligence era where humans and AI work together.
Builders VC is a venture firm run by operators and investors that backs founders solving complex, mission-critical problems in industries dominated by legacy systems.
Firms observed investing alongside KdT Ventures, from public investor directories. Shared companies are the overlap with KdT Ventures's recorded portfolio.
Similar investors
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
Giant Ventures is a venture capital firm investing across sectors including AI, climate, health, energy and fintech, and also incubates some of its own companies. Its portfolio spans roughly 48+ companies across the US and Europe.
Overwater Ventures is an early-stage venture firm that partners with pre-seed and seed stage founders working on large-scale problems, offering hands-on support across launch strategy, go-to-market, fundraising, and marketing.
Seafund is an early-stage venture capital firm that backs startups building in deeptech and deepscience, providing hands-on support alongside capital.
Ankur Capital is an early-stage venture firm that partners closely with founders across product strategy, hiring, customer and investor introductions, leveraging a network of founders, operators, and research institutions in India and globally.